Shah, Manish A

Publications

Sort by

Co-Author Network

selected publications

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer. Journal for immunotherapy of cancer. 2023 Academic Article GET IT
Improving outcomes in patients with oesophageal cancer. Nature reviews. Clinical oncology. 2023 Review GET IT
Long COVID in Cancer: A Matched Cohort Study of 1-year Mortality and Long COVID Prevalence Among Patients With Cancer Who Survived an Initial Severe SARS-CoV-2 Infection. American journal of clinical oncology. 2023 Academic Article GET IT
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial. Lancet (London, England). 2023 Academic Article GET IT
Times cited: 4
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline Q and A. JCO oncology practice. 2023 Academic Article GET IT
Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers. Nature communications. 2023 Academic Article GET IT
Times cited: 1
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2023 Academic Article GET IT
Times cited: 9
Circulating IgA Antibodies Against Fusobacterium nucleatum Amyloid Adhesin FadA are a Potential Biomarker for Colorectal Neoplasia. Cancer research communications. 2022 Academic Article GET IT
Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C Study. Clinical colorectal cancer. 2022 Academic Article GET IT
Nivolumab plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastroesophageal junction cancer-regional differences in efficacy. Annals of palliative medicine. 2022 Editorial Article GET IT
Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer. PloS one. 2022 Article GET IT
Pertuzumab, trastuzumab, and chemotherapy in HER2-positive gastric/gastroesophageal junction cancer: end-of-study analysis of the JACOB phase III randomized clinical trial. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2022 Comment GET IT
Times cited: 1
Adenoviral-based vaccine promotes neoantigen-specific CD8⁺ T cell stemness and tumor rejection. Science translational medicine. 2022 Academic Article GET IT
Times cited: 7
T cell-inflamed gene expression profile and PD-L1 expression and pembrolizumab efficacy in advanced esophageal cancer. Future oncology (London, England). 2022 Academic Article GET IT
Times cited: 1
Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2022 Academic Article GET IT
Randomized, double-blind, placebo-controlled phase 3 study of paclitaxel {plus minus} napabucasin in pretreated advanced gastric or gastroesophageal junction adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2022 Academic Article GET IT
Evaluating Alternative Ramucirumab Doses as a Single Agent or with Paclitaxel in Second-Line Treatment of Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma: Results from Two Randomized, Open-Label, Phase II Studies. Cancers. 2022 Academic Article GET IT
Times cited: 29
Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer. PloS one. 2021 Article GET IT
Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival. Journal for immunotherapy of cancer. 2021 Academic Article GET IT
Times cited: 14
CLIP-170S is a microtubule +TIP variant that confers resistance to taxanes by impairing drug-target engagement. Developmental cell. 2021 Academic Article GET IT
Times cited: 4
Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma. The oncologist. 2021 Academic Article GET IT
Times cited: 8
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study. Lancet (London, England). 2021 Academic Article GET IT
Times cited: 356
Dietary fructose improves intestinal cell survival and nutrient absorption. Nature. 2021 Academic Article GET IT
Times cited: 76
Immunotherapy in Patients With Locally Advanced Esophageal Carcinoma: ASCO Treatment of Locally Advanced Esophageal Carcinoma Guideline Rapid Recommendation Update. 2021 GET IT
Times cited: 10
Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer. Cell. 2021 Academic Article GET IT
Times cited: 68
Implications of reactive oxygen species on cancer formation and its treatment. Seminars in oncology. 2021 Review GET IT
Times cited: 13
Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing. The oncologist. 2021 Academic Article GET IT
Times cited: 6
Redefining Intermediate-Stage HCC Treatment in the Era of Immune Therapies. JCO oncology practice. 2021 Review GET IT
Times cited: 5
Favorable response to second-line atezolizumab and bevacizumab following progression on nivolumab in advanced hepatocellular carcinoma: A case report demonstrating that anti-VEGF therapy overcomes resistance to checkpoint inhibition. 2021 GET IT
Times cited: 3
Androgen receptor variant shows heterogeneous expression in prostate cancer according to differentiation stage. Communications biology. 2021 Academic Article GET IT
Times cited: 3
Impact of Use of Antibiotics on Response to Immune Checkpoint Inhibitors and Tumor Microenvironment. American journal of clinical oncology. 2021 Academic Article GET IT
Times cited: 13
Phase III Study to Evaluate Efficacy and Safety of Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2021 Academic Article GET IT
Times cited: 18
KEYNOTE-975 study design: a Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinoma. Future oncology (London, England). 2021 Academic Article GET IT
Times cited: 33
Reply to K. de Joode et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2021 Letter GET IT
Development of the Oncolo-GIST ("Giving Information Strategically & Transparently") Intervention Manual for Oncologist Skills Training in Advanced Cancer Prognostic Information Communication. Journal of pain and symptom management. 2020 Academic Article GET IT
Times cited: 4
Comparative effectiveness of treatment modalities in non-metastatic gastric adenocarcinoma: a propensity score matching analysis of the National Cancer Database. BMJ open gastroenterology. 2020 Academic Article GET IT
Times cited: 27
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020 Academic Article GET IT
Times cited: 463
Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors. Journal for immunotherapy of cancer. 2020 Academic Article GET IT
Times cited: 43
COVID-19 Severity and Outcomes in Patients With Cancer: A Matched Cohort Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020 Academic Article GET IT
Times cited: 93
Safety and Efficacy of Andecaliximab (GS-5745) Plus Gemcitabine and Nab-Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I Study. The oncologist. 2020 Academic Article GET IT
Times cited: 12
Clinical Screening for COVID-19 in Asymptomatic Patients With Cancer. JAMA network open. 2020 Academic Article GET IT
Times cited: 19
Metastatic Pancreatic Cancer: ASCO Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020 Academic Article GET IT
Times cited: 109
Hematology and oncology clinical care during the coronavirus disease 2019 pandemic. CA: a cancer journal for clinicians. 2020 Academic Article GET IT
Times cited: 12
Multicenter Phase II Study of Cabazitaxel in Advanced Gastroesophageal Cancer: Association of HER2 Expression and M2-Like Tumor-Associated Macrophages with Patient Outcome. Clinical cancer research : an official journal of the American Association for Cancer Research. 2020 Academic Article GET IT
Times cited: 6
Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline. 2020 GET IT
Times cited: 113
Microtubule Engagement with Taxane Is Altered in Taxane-Resistant Gastric Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2020 Academic Article GET IT
Times cited: 14
Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative. European journal of cancer (Oxford, England : 1990). 2020 Academic Article GET IT
Times cited: 12
ASCO Clinical Practice Guideline Endorsements and Adaptations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 Academic Article GET IT
Times cited: 6
Palliative Chemotherapy or Radiation and Prognostic Understanding among Advanced Cancer Patients: The Role of Perceived Treatment Intent. Journal of palliative medicine. 2019 Academic Article GET IT
Times cited: 10
A circadian clock is essential for homeostasis of group 3 innate lymphoid cells in the gut. Science immunology. 2019 Academic Article GET IT
Times cited: 58
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer. JCO precision oncology. 2019 Academic Article GET IT
Times cited: 36
The role of pembrolizumab in the treatment of PD-L1 expressing gastric and gastroesophageal junction adenocarcinoma. Therapeutic advances in gastroenterology. 2019 Review GET IT
Times cited: 298
Ramucirumab for the treatment of gastric or gastro-esophageal junction cancer. Expert opinion on biological therapy. 2019 Review GET IT
Times cited: 17
Cancer-Specific Thresholds Adjust for Whole Exome Sequencing-based Tumor Mutational Burden Distribution. JCO precision oncology. 2019 Academic Article GET IT
Times cited: 105
Pharmacokinetic and exposure-response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer. Cancer chemotherapy and pharmacology. 2019 Academic Article GET IT
Times cited: 5
Optimizing Therapies in the Perioperative Management of Gastric Cancer. Current treatment options in oncology. 2019 Review GET IT
Times cited: 12
Gastroesophageal Junction Adenocarcinoma: Is There an Optimal Management?. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2019 Review GET IT
Evaluation of a REDCap-based Workflow for Supporting Federal Guidance for Electronic Informed Consent. AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science. 2019 Academic Article GET IT
Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2. Nature. 2019 Academic Article GET IT
Times cited: 150
Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus: The Phase 2 KEYNOTE-180 Study. JAMA oncology. 2019 Academic Article GET IT
Times cited: 301
KEYNOTE-590: Phase III study of first-line chemotherapy with or without pembrolizumab for advanced esophageal cancer. Future oncology (London, England). 2019 Academic Article GET IT
Times cited: 101
Associations between Anxiety, Poor Prognosis, and Accurate Understanding of Scan Results among Advanced Cancer Patients. Journal of palliative medicine. 2019 Academic Article GET IT
Times cited: 16
Early Detection for Colorectal Cancer: ASCO Resource-Stratified Guideline. Journal of global oncology. 2019 Academic Article GET IT
Times cited: 35
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial. The Lancet. Oncology. 2019 Academic Article GET IT
Times cited: 162
Treatment of Patients With Early-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline. Journal of global oncology. 2019 Academic Article GET IT
Times cited: 90
Biomarker analysis of the GATSBY study of trastuzumab emtansine versus a taxane in previously treated HER2-positive advanced gastric/gastroesophageal junction cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2019 Academic Article GET IT
Times cited: 30
A Comparison of Homogenization vs. Enzymatic Lysis for Microbiome Profiling in Clinical Endoscopic Biopsy Tissue Samples. Frontiers in microbiology. 2019 Academic Article GET IT
Times cited: 64
Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study. The Lancet. Oncology. 2018 Academic Article GET IT
Times cited: 267
Oncologic and Palliative Care in a Global Setting in the Twenty-First Century: The Patient, Family, and Oncologic Health Care Team. Journal of global oncology. 2018 Editorial Article GET IT
Times cited: 1
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2018 Academic Article GET IT
Times cited: 14
ASCO Resource-Stratified Guidelines: Methods and Opportunities. 2018 GET IT
Times cited: 12
Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2018 Academic Article GET IT
Times cited: 170
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial. JAMA oncology. 2018 Comment GET IT
Times cited: 1120
Post-Treatment/Pre-operative PET Response Is Not an Independent Predictor of Outcomes for Patients With Gastric and GEJ Adenocarcinoma. Annals of surgery. 2018 Academic Article GET IT
Times cited: 9
Andecaliximab/GS-5745 Alone and Combined with mFOLFOX6 in Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Results from a Phase I Study. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Academic Article GET IT
Times cited: 63
Low molecular weight heparin versus rivaroxaban in the treatment of venous thromboembolism in gastrointestinal malignancies. 2018 GET IT
Times cited: 1
Being present: oncologists' role in promoting advanced cancer patients' illness understanding. Cancer medicine. 2018 Academic Article GET IT
Times cited: 6
The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI. BMC cancer. 2017 Academic Article GET IT
Times cited: 107
Chemotherapy Use, End-of-Life Care, and Costs of Care Among Patients Diagnosed With Stage IV Pancreatic Cancer. Journal of pain and symptom management. 2017 Academic Article GET IT
Times cited: 20
Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center: Postsurgical Outcomes in 41 Patients. Annals of surgery. 2017 Academic Article GET IT
Times cited: 44
Reply to M. Mo et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Letter GET IT
Times cited: 1
State of the Science: Cancer Complementary and Alternative Medicine Therapeutics Research-NCI Strategic Workshop Highlights of Discussion Report. Journal of the National Cancer Institute. Monographs. 2017 Article GET IT
Times cited: 8
Regional differences in advanced gastric cancer: exploratory analyses of the AVAGAST placebo arm. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2017 Academic Article GET IT
Times cited: 28
Gastric cancer: The gastric microbiota - bacterial diversity and implications. Nature reviews. Gastroenterology & hepatology. 2017 Comment GET IT
Times cited: 20
Antibody-drug conjugates: can the payload improve activity in HER2 expressing cancers?. The Lancet. Oncology. 2017 Comment GET IT
Oesophageal cancer. Nature reviews. Disease primers. 2017 Review GET IT
Times cited: 326
Early-onset Colorectal Cancer is Distinct From Traditional Colorectal Cancer. Clinical colorectal cancer. 2017 Academic Article GET IT
Times cited: 85
HELOISE: Phase IIIb Randomized Multicenter Study Comparing Standard-of-Care and Higher-Dose Trastuzumab Regimens Combined With Chemotherapy as First-Line Therapy in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Academic Article GET IT
Times cited: 88
Effect of Fluorouracil, Leucovorin, and Oxaliplatin With or Without Onartuzumab in HER2-Negative, MET-Positive Gastroesophageal Adenocarcinoma: The METGastric Randomized Clinical Trial. JAMA oncology. 2017 Academic Article GET IT
Times cited: 190
The Management of Esophagogastric Cancers Enters a New Era. Hematology/oncology clinics of North America. 2017 Editorial Article GET IT
Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study. The Lancet. Oncology. 2017 Academic Article GET IT
Times cited: 331
Future Directions in Improving Outcomes for Patients with Gastric and Esophageal Cancer. Hematology/oncology clinics of North America. 2017 Review GET IT
Times cited: 6
The Gastric Microbiome and Its Influence on Gastric Carcinogenesis: Current Knowledge and Ongoing Research. Hematology/oncology clinics of North America. 2017 Review GET IT
Times cited: 24
Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016 Academic Article GET IT
Times cited: 43
Use of positron emission tomography scan response to guide treatment change for locally advanced gastric cancer: the Memorial Sloan Kettering Cancer Center experience. Journal of gastrointestinal oncology. 2016 Academic Article GET IT
Times cited: 61
A Randomized Phase II Study of FOLFOX With or Without the MET Inhibitor Onartuzumab in Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction. The oncologist. 2016 Academic Article GET IT
Times cited: 76
Chemotherapy dose intensity predicted by baseline nutrition assessment in gastrointestinal malignancies: A multicentre analysis. European journal of cancer (Oxford, England : 1990). 2016 Academic Article GET IT
Times cited: 33
Development of an advance care planning paradigm for advanced cancer: person-centered oncologic care and choices (P-COCC). Psycho-oncology. 2016 Letter GET IT
Times cited: 12
Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 258
Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline. 2016 GET IT
Times cited: 216
High proportion of extrapulmonary tuberculosis in a low prevalence setting: a retrospective cohort study. Public health. 2016 Academic Article GET IT
Times cited: 26
Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease. Gastroenterology. 2016 Academic Article GET IT
Times cited: 116
Reply to O.O. Eren et al and S. Mikhail. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Letter GET IT
Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 104
Identification of low abundance microbiome in clinical samples using whole genome sequencing. Genome biology. 2015 Academic Article GET IT
Times cited: 64
Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma: A Study of the US Gastric Cancer Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Academic Article GET IT
Times cited: 149
Anaplastic thyroid cancer. Current opinion in endocrinology, diabetes, and obesity. 2015 Review GET IT
Times cited: 39
Chemotherapy Use, Performance Status, and Quality of Life at the End of Life. JAMA oncology. 2015 Academic Article GET IT
Times cited: 391
Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic Malignancies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 Academic Article GET IT
Times cited: 30
Lessons from the first ecancer symposium on angiogenesis in gastric cancer. Ecancermedicalscience. 2015 Academic Article GET IT
First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2015 Academic Article GET IT
Times cited: 183
Update on metastatic gastric and esophageal cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Review GET IT
Times cited: 162
Chemoradiation in oesophageal cancer. Best practice & research. Clinical gastroenterology. 2014 Review GET IT
Times cited: 17
Single nucleotide polymorphisms in AREG and EREG are prognostic biomarkers in locally advanced gastric cancer patients after surgery with curative intent. Pharmacogenetics and genomics. 2014 Academic Article GET IT
Times cited: 3
The germline CDH1 c.48 G>C substitution contributes to cancer predisposition through generation of a pro-invasive mutation. Mutation research. 2014 Academic Article GET IT
Times cited: 8
Template for Reporting Results of HER2 (ERBB2) Biomarker Testing of Specimens From Patients With Adenocarcinoma of the Stomach or Esophagogastric Junction. Archives of pathology & laboratory medicine. 2014 Academic Article GET IT
Times cited: 23
The role of ¹⁸F-FDG PET imaging in upper gastrointestinal malignancies. Current treatment options in oncology. 2014 Review GET IT
Times cited: 11
Gastric cancer drug trials - are women second class citizens?. Nature reviews. Clinical oncology. 2014 Comment GET IT
Phase II trial of cetuximab plus cisplatin and irinotecan in patients with cisplatin and irinotecan-refractory metastatic esophagogastric cancer. American journal of clinical oncology. 2014 Academic Article GET IT
Times cited: 7
The development of bevacizumab in noncolorectal gastrointestinal malignancies: gastroesophageal, pancreatic, and hepatocellular carcinoma. Clinical advances in hematology & oncology : H&O. 2014 Review GET IT
Times cited: 4
Thalidomide, clarithromycin, lenalidomide and dexamethasone therapy in newly diagnosed, symptomatic multiple myeloma. Leukemia & lymphoma. 2014 Academic Article GET IT
Times cited: 8
Is gastric cancer different in Korea and the United States? Impact of tumor location on prognosis. Annals of surgical oncology. 2014 Academic Article GET IT
Times cited: 55
Phase II trial of bortezomib alone or in combination with irinotecan in patients with adenocarcinoma of the gastroesophageal junction or stomach. Investigational new drugs. 2014 Academic Article GET IT
Times cited: 11
Stage-stratified prognosis of signet ring cell histology in patients undergoing curative resection for gastric adenocarcinoma. Annals of surgical oncology. 2014 Academic Article GET IT
Times cited: 89
Gastrointestinal cancer: targeted therapies in gastric cancer-the dawn of a new era. Nature reviews. Clinical oncology. 2013 Article GET IT
Times cited: 36
A case report of trastuzumab dose in gastric cancer. 2013 GET IT
Times cited: 7
Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2-based microfluidic device. Lab on a chip. 2013 Academic Article GET IT
Times cited: 81
Capecitabine in the treatment of esophageal and gastric cancers. Expert opinion on investigational drugs. 2013 Review GET IT
Times cited: 11
Met, IGF1R, and other new targets in upper GI malignancies. Current treatment options in oncology. 2013 Academic Article GET IT
Times cited: 2
Prognostic role of lemur tyrosine kinase-3 germline polymorphisms in adjuvant gastric cancer in Japan and the United States. Molecular cancer therapeutics. 2013 Academic Article GET IT
Times cited: 14
Phase II study evaluating 2 dosing schedules of oral foretinib (GSK1363089), cMET/VEGFR2 inhibitor, in patients with metastatic gastric cancer. PloS one. 2013 Academic Article GET IT
Times cited: 168
Unanswered questions in the management of gastroesophageal junction adenocarcinoma: an overview from the medical oncologist's perspective. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2013 Review GET IT
Times cited: 1
Comparison of disease-specific survival in the United States and Korea after resection for early-stage node-negative gastric carcinoma. Journal of surgical oncology. 2012 Academic Article GET IT
Times cited: 39
Conditional probability of survival nomogram for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancer. Annals of surgical oncology. 2012 Academic Article GET IT
Times cited: 50
Gastric cancer epidemiology and risk factors. Journal of surgical oncology. 2012 Review GET IT
Times cited: 385
Role of repeat staging laparoscopy in locoregionally advanced gastric or gastroesophageal cancer after neoadjuvant therapy. Annals of surgical oncology. 2012 Academic Article GET IT
Times cited: 25
Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis. Annals of oncology : official journal of the European Society for Medical Oncology. 2012 Academic Article GET IT
Times cited: 255
A man with Klinefelter's syndrome and new abdominal distension: a discussion of evaluation and management. 2012 GET IT
Times cited: 1
Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Academic Article GET IT
Times cited: 401
A 72-year-old man with duodenal adenocarcinoma. Gastrointestinal cancer research : GCR. 2012 Academic Article GET IT
A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer. Cancer. 2012 Academic Article GET IT
Times cited: 113
An individual coding polymorphism and the haplotype of the SPARC gene predict gastric cancer recurrence. The pharmacogenomics journal. 2012 Academic Article GET IT
Times cited: 5
Management of advanced gastric cancer. Expert review of gastroenterology & hepatology. 2012 Review GET IT
Times cited: 66
Tobacco use is associated with increased recurrence and death from gastric cancer. Annals of surgical oncology. 2012 Academic Article GET IT
Times cited: 40
A retrospective observational study on the use of capecitabine in patients with severe renal impairment (GFR <30 mL/min) and end stage renal disease on hemodialysis. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 2012 Academic Article GET IT
Times cited: 10
Gastrointestinal cancer educatinal case series: a 65 year-old female with locally advanced gastric cancer and a supraclavicular lymph node. 2012 GET IT
A 71-year-old man with a large cystic pancreatic mass. 2012 GET IT
Treatment of resectable gastric cancer. Therapeutic advances in gastroenterology. 2012 Academic Article GET IT
Times cited: 63
Will disease heterogeneity help define treatment paradigms for gastroesophageal adenocarcinoma? A global perspective. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2012 Academic Article GET IT
Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies. World journal of gastroenterology. 2011 Review GET IT
Times cited: 45
A woman with remotely treated pancreas cancer and new abdominal pain: a discussion of evaluation and management. 2011 GET IT
Human epidermal growth factor receptor 2 testing in gastroesophageal cancer: correlation between immunohistochemistry and fluorescence in situ hybridization. Archives of pathology & laboratory medicine. 2011 Academic Article GET IT
Times cited: 57
Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancer. Cancer. 2011 Academic Article GET IT
Times cited: 71
Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer. Cancer. 2011 Academic Article GET IT
Times cited: 64
A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma. 2011 GET IT
Times cited: 11
Gastrointestinal cancer educational case series: management of metastatic adenocarcinoma of unknown primary origin in a Ph+ ALL survivor. 2011 GET IT
Times cited: 1
Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Academic Article GET IT
Times cited: 952
De novo CDH1 mutation in a family presenting with early-onset diffuse gastric cancer. 2011 GET IT
Times cited: 22
Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients. Indian journal of surgical oncology. 2011 Academic Article GET IT
Times cited: 193
Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma. British journal of cancer. 2011 Academic Article GET IT
Times cited: 85
Molecular classification of gastric cancer: a new paradigm. Clinical cancer research : an official journal of the American Association for Cancer Research. 2011 Academic Article GET IT
Times cited: 250
MET expression and amplification in patients with localized gastric cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2011 Academic Article GET IT
Times cited: 131
GRP78 promoter polymorphism rs391957 as potential predictor for clinical outcome in gastric and colorectal cancer patients. Annals of oncology : official journal of the European Society for Medical Oncology. 2011 Academic Article GET IT
Times cited: 24
Gastrointestinal cancer educational case series: the history and management of complex cases in gi oncology. A 72 year-old man with metastatic gastric cancer. 2011 GET IT
Molecularly targeted therapies in advanced gastric cancer. Minerva gastroenterologica e dietologica. 2011 Review GET IT
Times cited: 11
Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma. International journal of cancer. 2011 Academic Article GET IT
Times cited: 32
Phase II study of modified docetaxel, cisplatin, and fluorouracil with bevacizumab in patients with metastatic gastroesophageal adenocarcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Academic Article GET IT
Times cited: 174
A phase 2 trial of erlotinib in patients with previously treated squamous cell and adenocarcinoma of the esophagus. Cancer. 2010 Academic Article GET IT
Times cited: 87
Upper gastrointestinal cancer predisposition syndromes. Hematology/oncology clinics of North America. 2010 Review GET IT
Times cited: 11
Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients. Annals of surgical oncology. 2010 Academic Article GET IT
Times cited: 141
A multicenter, phase II study of bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma. Investigational new drugs. 2010 Academic Article GET IT
Times cited: 44
Risk factors for developing a new venous thromboembolism in ambulatory patients with non-hematologic malignancies and impact on survival for gastroesophageal malignancies. Journal of thrombosis and haemostasis : JTH. 2010 Academic Article GET IT
Times cited: 35
Gastric cancer--an enigmatic and heterogeneous disease. JAMA. 2010 Editorial Article GET IT
Times cited: 92
Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Annals of surgery. 2010 Academic Article GET IT
Times cited: 297
Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease. Journal of the National Comprehensive Cancer Network : JNCCN. 2010 Review GET IT
Times cited: 168
A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol. Cancer chemotherapy and pharmacology. 2010 Academic Article GET IT
Times cited: 23
Advanced gastric cancer--slow but steady progress. Cancer treatment reviews. 2010 Review GET IT
Times cited: 132
Randomized clinical trials in gastric cancer. Surgical oncology clinics of North America. 2010 Review GET IT
Times cited: 5
Phase I study of flavopiridol with oxaliplatin and fluorouracil/leucovorin in advanced solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 Academic Article GET IT
Times cited: 48
Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation. American journal of clinical oncology. 2009 Academic Article GET IT
Times cited: 16
Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma. Annals of oncology : official journal of the European Society for Medical Oncology. 2009 Academic Article GET IT
Times cited: 45
Safety and efficacy of panitumumab following cetuximab: retrospective review of the Memorial Sloan-Kettering experience. Investigational new drugs. 2009 Academic Article GET IT
Times cited: 23
A phase II study of flavopiridol (Alvocidib) in combination with docetaxel in refractory, metastatic pancreatic cancer. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]. 2009 Academic Article GET IT
Times cited: 39
How should we care for elderly cancer patients?. Oncology (Williston Park, N.Y.). 2009 Comment GET IT
Times cited: 5
Endoscopic ultrasound can improve the selection for laparoscopy in patients with localized gastric cancer. Journal of the American College of Surgeons. 2008 Academic Article GET IT
Times cited: 76
HER kinase activation confers resistance to MET tyrosine kinase inhibition in MET oncogene-addicted gastric cancer cells. Molecular cancer therapeutics. 2008 Academic Article GET IT
Times cited: 110
A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2008 Academic Article GET IT
Times cited: 55
The Quality of Quality-of-Life and Cost-Effectiveness Analyses. Gastrointestinal cancer research : GCR. 2008 Academic Article GET IT
Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer. Cancer chemotherapy and pharmacology. 2008 Academic Article GET IT
Times cited: 42
E-cadherin gene alterations in gastric cancers in different ethnic populations. Ethnicity & disease. 2008 Academic Article GET IT
Times cited: 11
Pneumatosis intestinalis: a variant of bevacizumab related perforation possibly associated with chemotherapy related GI toxicity. 2007 GET IT
Times cited: 38
Systemic chemotherapy does not increase the risk of gastrointestinal perforation. Annals of oncology : official journal of the European Society for Medical Oncology. 2007 Academic Article GET IT
Times cited: 9
Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?. Annals of surgical oncology. 2007 Academic Article GET IT
Times cited: 87
Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Academic Article GET IT
Times cited: 81
Dynamic changes in conduction velocity and gap junction properties during development of pacing-induced heart failure. American journal of physiology. Heart and circulatory physiology. 2007 Academic Article GET IT
Times cited: 164
Incorporation of biologic therapies in the management of gastroesophageal cancers. Gastrointestinal cancer research : GCR. 2007 Academic Article GET IT
Outcome of patients with known metastatic gastric cancer undergoing resection with therapeutic intent. Annals of surgical oncology. 2007 Academic Article GET IT
Times cited: 38
Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 412
A multi-center phase II study of BMS-247550 (Ixabepilone) by two schedules in patients with metastatic gastric adenocarcinoma previously treated with a taxane. Investigational new drugs. 2006 Academic Article GET IT
Times cited: 37
A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 2006 Academic Article GET IT
Times cited: 48
Gastric cancer: an update. Current oncology reports. 2006 Review GET IT
Times cited: 7
Targeting the cell cycle: a new approach to cancer therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Review GET IT
Times cited: 656
Molecular basis of arrhythmias. Circulation. 2005 Review GET IT
Times cited: 136
A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridol. Clinical cancer research : an official journal of the American Association for Cancer Research. 2005 Academic Article GET IT
Times cited: 100
Drg1 expression in 131 colorectal liver metastases: correlation with clinical variables and patient outcomes. Clinical cancer research : an official journal of the American Association for Cancer Research. 2005 Academic Article GET IT
Times cited: 61
Thromboembolic events in gastric cancer: high incidence in patients receiving irinotecan- and bevacizumab-based therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Letter GET IT
Times cited: 117
Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with Fluorouracil in patients with advanced solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 104
Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 1066
Cyclin-dependent kinases as targets for cancer therapy. Cancer chemotherapy and biological response modifiers. 2005 Review GET IT
Times cited: 12
Treatment of metastatic esophagus and gastric cancer. Seminars in oncology. 2004 Review GET IT
Times cited: 58
Combined modality therapy of esophageal cancer: changes in the standard of care?. Annals of surgical oncology. 2004 Editorial Article GET IT
Times cited: 11
Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases. British journal of cancer. 2004 Academic Article GET IT
Times cited: 117
Cyclin-dependent kinases as targets for cancer therapy. Cancer chemotherapy and biological response modifiers. 2003 Review GET IT
Times cited: 16
Staphylococcus aureus bacteremia in patients with neutropenia. Southern medical journal. 2002 Letter GET IT
Times cited: 5
Recent developments in the treatment of gastric carcinoma. Current oncology reports. 2002 Review GET IT
Times cited: 9
[Postoperative adjuvant chemoradiotherapy in high risk stomach carcinoma]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 2002 Academic Article GET IT
Times cited: 1
Augmentation of apoptosis and tumor regression by flavopiridol in the presence of CPT-11 in Hct116 colon cancer monolayers and xenografts. Clinical cancer research : an official journal of the American Association for Cancer Research. 2001 Academic Article GET IT
Times cited: 110
Cell cycle-mediated drug resistance: an emerging concept in cancer therapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2001 Review GET IT
Times cited: 389
Infection of orthopedic prostheses after Staphylococcus aureus bacteremia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2001 Academic Article GET IT
Times cited: 211
The relevance of drug sequence in combination chemotherapy. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy. 2000 Academic Article GET IT
Times cited: 39
Prospective analysis of Staphylococcus aureus bacteremia in nonneutropenic adults with malignancy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2000 Academic Article GET IT
Times cited: 53

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

Clinical and Translational Science Center - UL1 awarded by National Center for Advancing Translational Sciences Co-Investigator 2022 - 2027
A novel, short isoform of the +TIP microtubule (MT) binding protein CLIP170 confers taxane resistance by obstructing the MT pore. awarded by National Cancer Institute Co-Investigator 2018 - 2024

more ...

less ...

Background

education and training

M.D., Harvard University and Massachusetts Institute of Technology - Division of Health Sciences and Technology 1996
B.S.E., The Johns Hopkins University 1991

Contact

full name

Manish A Shah

primary email

mas9313@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Manish A Shah Professor of Medicine

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

webpage